QANDLI DIABET PATOGENEZIDA UGLEVOD VA LIPID ALMASHINUVINING O‘ZARO BOG‘LIQLIGI VA BUZILISH MEXANIZMLARI
- Authors
-
-
Olimov Timur
Andijon davlat tibbiyot instituti, Davolash fakulteti 219-guruh talabasi
Author
-
- Keywords:
- Array
- Abstract
-
Maqolada 2-tip qandli diabetda uglevod va lipid almashinuvi buzilishlarining o‘zaro bog‘liqligi ilmiy manbalar asosida tahlil qilindi. Insulinrezistentlik, lipotoksiklik va β-hujayra disfunksiyasi yoritildi. Lipid metabolitlarining insulin signali va sekretsiyasiga ta’siri ko‘rsatildi. Xulosalar inson, hujayra va hayvon tadqiqotlari dalillari bilan baholandi.
- References
-
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1(7285):785–789. doi:10.1016/S0140-6736(63)91500-9.
Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97(12):2859–2865. doi:10.1172/JCI118742.
Szendroedi J, Yoshimura T, Phielix E, et al. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci USA. 2014;111(26):9597–9602. doi:10.1073/pnas.1409229111.
Perry RJ, Camporez JPG, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745–758. doi:10.1016/j.cell.2015.01.012.
Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA. 1998;95(5):2498–2502. doi:10.1073/pnas.95.5.2498.
Hall E, Jönsson J, Ofori JK, et al. Glucolipotoxicity alters insulin secretion via epigenetic changes in human islets. Diabetes. 2019;68(10):1965–1974. doi:10.2337/db18-0900.
Oberhauser L, Jiménez-Sánchez C, Madsen JGS, et al. Glucolipotoxicity promotes the capacity of the glycerolipid/NEFA cycle supporting the secretory response of pancreatic beta cells. Diabetologia. 2022;65(4):705–720. doi:10.1007/s00125-021-05633-x.
Velagapudi S, Karsai G, Karsai M, et al. Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes. Cardiovasc Res. 2024;120(11):1265–1278. doi:10.1093/cvr/cvae100.
Naderi J, Johnson AK, Thakkar H, et al. Ceramide-induced FGF13 impairs systemic metabolic health. Cell Metab. 2025;37(5):1206–1222.e8. doi:10.1016/j.cmet.2025.03.002.
Hu X, Guo L, Toledo MP, et al. Molecular mechanisms of human pancreatic islet dysfunction under overnutrition metabolic stress. Diabetes. 2025;74(10):1825–1838. doi:10.2337/db24-1038.
Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–2514. doi:10.1007/s00125-011-2204-7.
- Downloads
- Published
- 2026-11-18
- Section
- Articles